Valneva hosts investor day in new york city

Live event and webcast today at 10 am et saint herblain (france), october 10, 2024 –valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, is hosting an investor day today in new york city to discuss the company's key value drivers over the next 12-18 months and beyond. valneva's chief executive officer thomas lingelbach, chief financial officer peter bÜhler, and other members of the company's senior leadership team will highlight the company's substantial opportunity for its lyme disease vaccine candidate led by partner pfizer, valneva's growing commercial vaccine business, and opportunities for continued value creation from the company's promising r&d pipeline.
VALN Ratings Summary
VALN Quant Ranking